Triasima Portfolio Management’s Guardant Health GH Stock Holding History

Triasima Portfolio Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.09M	Buy	+34,139	New	+$5.58M	0.8%	36

Other funds holding GH

Krilogy Financial St. Louis, Missouri $3.66B AUM 22.28% 1-Year Est. Return

MAG

MRA Advisory Group Parsippany, New Jersey $267M AUM 19.2% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return

GIA

Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.91B AUM 26.66% 1-Year Est. Return

FFAS

FIG Financial Advisory Services Oklahoma City, Oklahoma $165M AUM 16.79% 1-Year Est. Return

Avior Wealth Management Omaha, Nebraska $3.79B AUM 15.36% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return

CPBTD

Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return

Triasima Portfolio Management's GH Position: Q3 2026 in Review

Triasima Portfolio Management opened a new position in Guardant Health (GH) in Q3 2026: 34,139 shares worth $6.09M. The stake represents 0.8% of the portfolio and ranks #36 among its holdings.

51 funds tracked by Wall St. Rank hold GH as of Q3 2026.

Triasima Portfolio Management held 34,139 shares of Guardant Health worth $6.09M as of Q3 2026.
Guardant Health was a new Triasima Portfolio Management position in Q3 2026.
Guardant Health made up 0.8% of Triasima Portfolio Management's portfolio in Q3 2026, its #36 holding.
51 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Triasima Portfolio Management's 13F filing for Q3 2026, filed 15 Oct 2026.